Liminal Biosciences Inc (LMNL)

1.26 +0.02  +1.61% NASDAQ Nov 29, 16:00 1.29 +0.03  +2.38% After-Hours: 04:47 USD

Liminal Biosciences SG&A Expense (Quarterly):

7.479M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

SG&A Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Historical SG&A Expense (Quarterly) Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 7.479M
June 30, 2021 6.963M
March 31, 2021 7.211M
Dec. 31, 2020 10.31M
Sept. 30, 2020 5.653M
June 30, 2020 6.134M
March 31, 2020 7.944M
Dec. 31, 2019 7.786M
Sept. 30, 2019 7.467M
June 30, 2019 13.48M
March 31, 2019 5.334M
Dec. 31, 2018 6.488M
Sept. 30, 2018 4.759M
June 30, 2018 5.381M
March 31, 2018 6.099M
Dec. 31, 2017 5.427M
Sept. 30, 2017 6.105M
June 30, 2017 5.992M
March 31, 2017 5.245M
Dec. 31, 2016 8.981M
Sept. 30, 2016 4.964M
June 30, 2016 4.023M
March 31, 2016 3.516M
Dec. 31, 2015 3.991M
Sept. 30, 2015 3.156M
   
June 30, 2015 3.065M
March 31, 2015 2.703M
Dec. 31, 2014 3.382M
Sept. 30, 2014 2.929M
June 30, 2014 2.468M
March 31, 2014 1.930M
Dec. 31, 2013 3.584M
Sept. 30, 2013 1.907M
June 30, 2013 1.271M
March 31, 2013 1.486M
Dec. 31, 2012 1.938M
Sept. 30, 2012 1.25M
June 30, 2012 1.254M
March 31, 2012 1.395M
Dec. 31, 2011 1.366M
Sept. 30, 2011 1.453M
June 30, 2011 1.440M
March 31, 2011 1.596M
Dec. 31, 2010 1.322M
Sept. 30, 2010 1.279M
June 30, 2010 1.284M
March 31, 2010 1.456M
Dec. 31, 2009 1.025M
Sept. 30, 2009 0.9297M
June 30, 2009 1.023M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Benchmarks

Aurinia Pharmaceuticals Inc 44.13M
Edesa Biotech Inc 1.608M
Xenon Pharmaceuticals Inc 4.831M

SG&A Expense (Quarterly) Range, Past 5 Years

Minimum 4.759M Sep 2018
Maximum 13.48M Jun 2019
Average 7.012M

News

LMNL, SONO, JRJC and WDC among after hours movers
SA Breaking News 08/13 17:40 ET
Top Midday Gainers
MT Newswires 08/09 13:35 ET
WPG, NCTY, ANY among mid-day movers
SA Breaking News 08/09 12:38 ET
NVTA, SOS and HVBT among pre market gainers
SA Breaking News 08/09 08:52 ET
Hot Stocks: M&A, FDA approval, and the next AMC?
SA Breaking News 06/07 09:04 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.